#prac — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #prac, aggregated by home.social.
-
At its June meeting, EMA's #safety committee, the #PRAC, carried out its work to assess all aspects of risk management related to the use of #medicines.
More information in our meeting highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-5-8-june-2023
🐦🔗: https://n.respublicae.eu/EMA_News/status/1667127819984306176
-
If an unusual pattern emerged, the #PRAC performed an in-depth analysis of the reports to quickly identify potential safety issues with #Covid19vaccines.
The 🇪🇺 pharmacovigilance system showed that it can detect and manage emerging #safety issues quickly.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666080058241581057
-
We placed extra obligations on the #Covid19vaccine makers.
They had to provide us with detailed monthly reports on the #safety of their vaccine ➡️ 5⃣6⃣monthly reports were assessed by our safety committee, the #PRAC, until December 2022.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666079498784366597
-
EMA's #safety committee, the #PRAC, carried out its work to assess all aspects of risk management related to the use of #medicines.
More information in our meeting highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-13-16-march-2023
🐦🔗: https://n.respublicae.eu/EMA_News/status/1636691621998673920
-
At its February meeting, EMA's safety committee, the #PRAC, started a safety review of medicines containing pseudoephedrine.
#PublicHealth #SafetyOfMedicines
🐦🔗: https://n.respublicae.eu/EMA_News/status/1624037832950939650
-
At its January meeting, our safety committee 🔎💊, the #PRAC, recommended aligning dose recommendations for Janus kinase inhibitors for chronic inflammatory disorders.
#chronicillness #SafetyOfMedicines
Read more in our highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-9-12-january-2023
🐦🔗: https://n.respublicae.eu/EMA_News/status/1613886224040710148
-
RT @EMA_News: At its January meeting, our safety committee 🔎💊, the #PRAC, recommended aligning dose recommendations for Janus kinase inhibitors for chronic inflammatory disorders.
#chronicillness #SafetyOfMedicines
Read more in our highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-9-12-january-2023
🐦🔗: https://n.respublicae.eu/Food_EU/status/1613888043802394627